Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
7.32
-0.17 (-2.27%)
At close: Apr 1, 2025, 4:00 PM
7.38
+0.06 (0.82%)
After-hours: Apr 1, 2025, 7:55 PM EDT
Zevra Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 33.79 | 43.05 | 65.47 | 112.35 | 4.21 | Upgrade
|
Short-Term Investments | 35.71 | 24.69 | 17.38 | - | - | Upgrade
|
Cash & Short-Term Investments | 69.5 | 67.74 | 82.85 | 112.35 | 4.21 | Upgrade
|
Cash Growth | 2.60% | -18.24% | -26.26% | 2566.65% | 30.96% | Upgrade
|
Accounts Receivable | 10.18 | 16.12 | 7.19 | 1.42 | 2.44 | Upgrade
|
Other Receivables | 0.33 | 1.26 | 1.11 | 0.11 | 0.14 | Upgrade
|
Receivables | 10.51 | 17.38 | 8.3 | 1.53 | 2.58 | Upgrade
|
Inventory | 1.97 | - | - | - | - | Upgrade
|
Prepaid Expenses | 4.05 | 1.82 | 1.69 | 0.89 | 0.66 | Upgrade
|
Restricted Cash | - | - | - | - | 0.11 | Upgrade
|
Other Current Assets | - | - | - | 0.29 | 0.83 | Upgrade
|
Total Current Assets | 86.03 | 86.94 | 92.83 | 115.06 | 8.38 | Upgrade
|
Property, Plant & Equipment | 1.01 | 1.53 | 1.78 | 2.03 | 2.39 | Upgrade
|
Long-Term Investments | 6.01 | - | 20 | 15.42 | - | Upgrade
|
Goodwill | 4.7 | 4.7 | - | - | - | Upgrade
|
Other Intangible Assets | 68.99 | 69.23 | - | - | - | Upgrade
|
Long-Term Accounts Receivable | - | - | - | - | 0.4 | Upgrade
|
Other Long-Term Assets | 11.38 | 9.94 | 0.72 | 0.44 | 0.04 | Upgrade
|
Total Assets | 178.13 | 172.33 | 115.34 | 132.94 | 11.21 | Upgrade
|
Accounts Payable | 13.08 | 13.99 | 3.61 | 0.52 | 1.17 | Upgrade
|
Accrued Expenses | 17.37 | 18.97 | 7.21 | 2.52 | 5.47 | Upgrade
|
Short-Term Debt | - | 37.7 | - | - | - | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 0.39 | Upgrade
|
Current Portion of Leases | 0.42 | 0.54 | 0.49 | 0.37 | 0.5 | Upgrade
|
Other Current Liabilities | 3.2 | 2.52 | 0.71 | 0.82 | - | Upgrade
|
Total Current Liabilities | 34.07 | 73.72 | 12.02 | 4.23 | 7.54 | Upgrade
|
Long-Term Debt | 59.5 | 5.07 | 12.8 | - | 68.05 | Upgrade
|
Long-Term Leases | 0.37 | 0.46 | 0.84 | 1.24 | 1.61 | Upgrade
|
Other Long-Term Liabilities | 44.52 | 31.22 | 14.55 | 0.36 | 0.43 | Upgrade
|
Total Liabilities | 138.46 | 110.46 | 40.22 | 5.82 | 77.62 | Upgrade
|
Common Stock | 0.01 | 0 | 0 | 0 | - | Upgrade
|
Additional Paid-In Capital | 555.3 | 472.66 | 436.27 | 396.96 | 192.06 | Upgrade
|
Retained Earnings | -505.29 | -399.78 | -353.73 | -267.03 | -258.47 | Upgrade
|
Treasury Stock | -10.98 | -10.98 | -7.54 | -2.81 | - | Upgrade
|
Comprehensive Income & Other | 0.63 | -0.04 | 0.11 | - | - | Upgrade
|
Total Common Equity | 39.67 | 61.86 | 75.12 | 127.12 | -66.41 | Upgrade
|
Shareholders' Equity | 39.67 | 61.86 | 75.12 | 127.12 | -66.41 | Upgrade
|
Total Liabilities & Equity | 178.13 | 172.33 | 115.34 | 132.94 | 11.21 | Upgrade
|
Total Debt | 60.3 | 43.77 | 14.13 | 1.61 | 70.55 | Upgrade
|
Net Cash (Debt) | 9.2 | 23.97 | 68.72 | 110.74 | -66.33 | Upgrade
|
Net Cash Growth | -61.62% | -65.11% | -37.95% | - | - | Upgrade
|
Net Cash Per Share | 0.20 | 0.68 | 1.99 | 3.72 | -16.66 | Upgrade
|
Filing Date Shares Outstanding | 54.12 | 41.85 | 34.54 | 34.42 | 28.38 | Upgrade
|
Total Common Shares Outstanding | 53.67 | 41.53 | 34.54 | 35.01 | 4.54 | Upgrade
|
Working Capital | 51.96 | 13.22 | 80.81 | 110.83 | 0.85 | Upgrade
|
Book Value Per Share | 0.74 | 1.49 | 2.17 | 3.63 | -14.64 | Upgrade
|
Tangible Book Value | -34.03 | -12.06 | 75.12 | 127.12 | -66.41 | Upgrade
|
Tangible Book Value Per Share | -0.63 | -0.29 | 2.17 | 3.63 | -14.64 | Upgrade
|
Machinery | 1.36 | 1.51 | 1.28 | 1.05 | 1.01 | Upgrade
|
Leasehold Improvements | 0.71 | 0.71 | 0.71 | 0.72 | 0.72 | Upgrade
|
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.